Recent studies highlight breakthroughs in medical treatments. A novel monoclonal antibody cocktail has shown promise in ...

Adding a monoclonal antibody cocktail to the standard treatment for inoperable liver cancer nearly doubled the amount of time ...

Adding camrelizumab and rivoceranib to transarterial chemoembolization (TACE) significantly prolonged progression-free ...

Liver cancer is a serious and deadly cancer ... pembrolizumab, and transarterial chemoembolization (TACE) significantly improves progression-free survival compared to TACE alone, addressing ...

Chemotherapy uses anti cancer (cytotoxic) drugs to destroy cancer cells. Chemoembolisation is a treatment directly into the liver. You have chemotherapy into the blood vessel that feeds the tumour.

Merck & Co. and Eisai have to deal with the reality that yet another phase 3 trial of their combination of Keytruda and ...

The interventional oncology market valued at US$ 2.53 Billion in 2023, is forecasted to grow at a robust CAGR of 9.0%, ...

The addition of lenvatinib/pembrolizumab to TACE showed a numerical improvement in PFS, but longer follow-up is necessary to ...

Adding a monoclonal antibody cocktail to the standard treatment for inoperable liver cancer nearly ... called transarterial chemoembolization (TACE), which shrinks the cancer by delivering ...